The role of antiplatelet therapy in aneurysm coiling

Neurological Research
|March 13, 2014
PubMed

Insights

Antiplatelet therapy is safe and effective for reducing thromboembolic risks during neurointerventional surgery for intracranial aneurysms. Further research is needed to minimize these risks, especially during aneurysm coiling.

Area of Science:

  • Neurology
  • Neurosurgery
  • Cardiovascular Medicine

Background:

  • Neurointerventional surgery enables advanced intravascular therapies for neurovascular diseases and stroke.
  • Thromboembolism is a significant complication in neurointerventional procedures, particularly for intracranial aneurysms.
  • Both antiplatelet and anticoagulant therapies are employed to mitigate thromboembolic risks.

Purpose of the Study:

  • To review the role of antiplatelet therapy in the endovascular management of intracranial aneurysms.
  • To assess the safety and efficacy of antiplatelet agents in reducing thrombotic risk.
  • To evaluate the use of abciximab as a salvage therapy.

Main Methods:

  • Literature review focusing on antiplatelet therapy in endovascular aneurysm treatment.
  • Analysis of studies on pre-procedural and intra-procedural antiplatelet use.
  • Examination of case reports and studies involving abciximab for thrombus management.

Main Results:

  • Antiplatelet agents appear safe and effective for reducing thrombotic risk in unruptured aneurysms.
  • Abciximab shows potential safety as a salvage therapy for thrombus formation in ruptured aneurysms with low hemorrhagic complication rates.
  • Further innovation is required to enhance safety and reduce thromboembolic events in aneurysm coiling.

Conclusions:

  • Antiplatelet therapy is a valuable tool in reducing thromboembolic complications during endovascular aneurysm treatment.
  • Abciximab may serve as a safe option in specific scenarios of thrombus formation.
  • Continued research is essential for optimizing neurointerventional strategies against thromboembolism.

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.6K
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
478
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
655
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
621
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K